Popescu, R; Ciardiello, F; Stahel, R (2014). Reply to the letter to the editor 'Still a long way to go to achieve multidisciplinarity for the benefit of patients: commentary on the ESMO position paper' by Valentini et al. Annals of Oncology, 25(9):1865.
Ciardiello, F; Arnold, D; Casali, P G; Cervantes, A; Douillard, J-Y; Eggermont, A; Eniu, A; McGregor, K; Peters, S; Piccart, M; Popescu, R; Van Cutsem, E; Zielinski, C; Stahel, R (2014). Delivering Precision Medicine in Oncology Today and in Future-The Promise and Challenges of Personalised Cancer Medicine: a position paper by the European Society for Medical Oncology (ESMO). Annals of Oncology, 25(9):1673-1678.
Pavlidis, N; Gatzemeier, W; Popescu, R; Stahel, R; Pinedo, H; Cavalli, F; Costa, A (2010). The masterclass of the european school of oncology: the 'key educational event' of the school. European Journal of Cancer, 46(12):2159-2165.
Ruhstaller, T; Widmer, L; Schuller, J C; Roth, A; Hess, V; Mingrone, W; von Moos, R; Borner, M; Pestalozzi, B C; BalmerMajno, S; Koberle, D; Terraciano, L; Schnider, A; Bodis, S; Popescu, R; Swiss Group for Clinical Cancer Research (SAKK) (2009). Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of Oncology, 20(9):1522-1528.